Cite this article
149
Downloads
4
Citations
338
Views
Announcements
Open Access
Review
Aging and Cardiovascular Disease: Current Status and Challenges
Show Less
1
Vanke School of Public Health, Tsinghua University, 10084 Beijing, China
2
School of Medicine, Tsinghua University, 10084 Beijing, China
3
Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China
4
Department of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University), 400038 Chongqing, China
*Correspondence: liangwn@tsinghua.edu.cn (Wannian Liang)
†These authors contributed equally.
Academic Editor: Jerome L. Fleg
†These authors contributed equally.
Academic Editor: Jerome L. Fleg
Rev. Cardiovasc. Med. 2022, 23(4), 135;
https://doi.org/10.31083/j.rcm2304135
Submitted: 30 December 2021 | Revised: 10 March 2022 | Accepted: 10 March 2022 | Published: 8 April 2022
(This article belongs to the Special Issue Heart Health and Aging)
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract
Cardiovascular disease (CVD) is the leading cause of death worldwide. Population aging is becoming the most important driver of the CVD epidemic. With the rapid increase in an aging population, the burden of CVD will continuously increase. Most old people also suffer multimorbidity, which is strongly associated with impaired quality of life, disability, dependence, and mortality. However, few reviews evaluated the CVD burden accompanied by population aging and the challenges of CVD care in elderly individuals with multimorbidity. This review identified and summarized the current status of the CVD epidemic associated with aging and highlighted the challenges and needs of CVD care for the elderly.
Keywords
aging
cardiovascular disease
epidemiology
multimorbidity
deprescribing
Figures
Fig. 1.